| 1. |
|
|
| 2. |
|
|
| 3. |
- Wagner, C A, et al.
(författare)
-
Effects of the serine/threonine kinase SGK1 on the epithelial Na(+) channel (ENaC) and CFTR : implications for cystic fibrosis.
- 2001
-
Ingår i: Cellular Physiology and Biochemistry. - 1015-8987 .- 1421-9778. ; 11:4
-
Tidskriftsartikel (refereegranskat)abstract
- Cystic fibrosis (CF) is characterized by impaired Cl(-) secretion and increased Na(+) reabsorption in several tissues including respiratory epithelium. Many CFTR mutations have been identified over the past years. However, only a poor correlation between the genotype and lung phenotype was found suggesting additional factors influencing the phenotype and course of the disease. The serine/threonine kinase SGK1 has recently been shown to stimulate the activity of the epithelial Na(+) channel ENaC. A variety of stimuli such as aldosterone, cell shrinkage, insulin or TGF-beta1 stimulate transcription and activate the SGK1 kinase. Here we further examined the effects of SGK1 on ENaC and CFTR which have mutual interactions and we analyzed sgk1 mRNA abundance in lung tissue from CF patients. Coexpression of CFTR and h-SGK1 in Xenopus oocytes increased ENaC currents as previously described. In addition CFTR mediated currents were also stimulated. h-SGK1 accelerated the expression of the amiloride sensitive Na(+)- current in Xenopus oocytes paralleled by increased ENaC-protein abundance in the oocyte membrane, an effect which was reversed by a h-SGK1(K127R) mutation lacking the ATP-binding site. The cation selectivity or Na(+) affinity were not affected. However, coexpression of h-SGK1 with ENaC altered the sensitivity of the Na(+)-channel to the inhibitors amiloride and triamterene. The inhibitory effect of CFTR expression on ENaC current was not affected by coexpression of h-SGK1 in Xenopus oocytes. Lung tissue from CF patients strongly expressed the serine/threonine kinase h-sgk1 which was not the case for non-CF lung tissue. Loss of CFTR function itself in a CF lung epithelial cell line did not increase SGK1 expression. In summary, enhanced expression of h-SGK1 in epithelial cells of CF-lung tissue may be a novel pathophysiological factor contributing to increased Na(+) channel activity and thus to increased Na(+) transport in CF.
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
- Olsen, Thale Kristin, et al.
(författare)
-
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
- 2022
-
Ingår i: JCI Insight. - : AMER SOC CLINICAL INVESTIGATION INC. - 2379-3708. ; 7:17
-
Tidskriftsartikel (refereegranskat)abstract
- Despite intensive therapy, children with high-risk neuroblastoma are at risk of treatment failure. We applied a multiomic system approach to evaluate metabolic vulnerabilities in human neuroblastoma. We combined metabolomics, CRISPR screening, and transcriptomic data across more than 700 solid tumor cell lines and identified dihydroorotate dehydrogenase (DHODH), a critical enzyme in pyrimidine synthesis, as a potential treatment target. Of note, DHODH inhibition is currently under clinical investigation in patients with hematologic malignancies. In neuroblastoma, DHODH expression was identified as an independent risk factor for aggressive disease, and high DHODH levels correlated to worse overall and event-free survival. A subset of tumors with the highest DHODH expression was associated with a dismal prognosis, with a 5-year survival of less than 10%. In xenograft and transgenic neuroblastoma mouse models treated with the DHODH inhibitor brequinar, tumor growth was dramatically reduced, and survival was extended. Furthermore, brequinar treatment was shown to reduce the expression of MYC targets in 3 neuroblastoma models in vivo. A combination of brequinar and temozolomide was curative in the majority of transgenic TH-MYCN neuroblastoma mice, indicating a highly active clinical combination therapy. Overall, DHODH inhibition combined with temozolomide has therapeutic potential in neuroblastoma, and we propose this combination for clinical testing.
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
- Spangenberg, C, et al.
(författare)
-
Disrespectful type IV pilins
- 1997
-
Ingår i: Molecular microbiology. - 0950-382X. ; 25:1, s. 203-204
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
|
|
| 11. |
- Stiel, H., et al.
(författare)
-
2D and 3D Nanoscale Imaging Using High Repetition Rate Laboratory-Based Soft X-Ray Sources
- 2018
-
Ingår i: X-Ray Lasers 2016 - Proceedings of the 15th International Conference on X-Ray Lasers. - Cham : Springer International Publishing. - 9783319730240 ; 202, s. 265-272
-
Konferensbidrag (refereegranskat)abstract
- In this contribution, we report about tomographic nanoscale imaging using a laser-produced plasma-based laboratory transmission X-ray microscope (LTXM) in the water window. The soft X-ray radiation of the LTXM is provided by a high average power laser-produced (1.3 kHz repetition rate, 0.5 ns pulse duration, 140 W average power) plasma source, a multilayer condenser mirror, an objective zone plate, and a back-illuminated CCD camera as a detector. In the second part of the contribution, we will present recent results on holography and coherent diffraction imaging using our high repetition rate X-ray laser. We will discuss advantages of these methods and its potential for nanoscale imaging.
|
|
| 12. |
|
|
| 13. |
|
|
| 14. |
- Tummler, C, et al.
(författare)
-
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro
- 2019
-
Ingår i: Cancers. - : MDPI AG. - 2072-6694. ; 11:2
-
Tidskriftsartikel (refereegranskat)abstract
- Neuroblastoma is a malignancy arising from the developing sympathetic nervous system and the most common and deadly cancer of infancy. New therapies are needed to improve the prognosis for high-risk patients and to reduce toxicity and late effects. Spleen tyrosine kinase (SYK) has previously been identified as a promising drug target in various inflammatory diseases and cancers but has so far not been extensively studied as a potential therapeutic target in neuroblastoma. In this study, we observed elevated SYK gene expression in neuroblastoma compared to neural crest and benign neurofibroma. While SYK protein was detected in the majority of examined neuroblastoma tissues it was less frequently observed in neuroblastoma cell lines. Depletion of SYK by siRNA and the use of small molecule SYK inhibitors significantly reduced the cell viability of neuroblastoma cell lines expressing SYK protein. Moreover, SYK inhibition decreased ERK1/2 and Akt phosphorylation. The SYK inhibitor BAY 613606 enhanced the effect of different chemotherapeutic drugs. Transient expression of a constitutive active SYK variant increased the viability of neuroblastoma cells independent of endogenous SYK levels. Collectively, our findings suggest that targeting SYK in combination with conventional chemotherapy should be further evaluated as a treatment option in neuroblastoma.
|
|
| 15. |
|
|
